Immunoassay Detection (Lateral Flow)

Rapid lateral flow immunoassay devices for professional laboratory and point-of-care settings — 75 devices in total, covering 13 clinical series.

EU regulatory status

165 devices listed in the Notified Body confirmation letter (TÜV Rheinland, NB 0197, 2026-07-10) under Regulation (EU) 2024/1860 — transition to 2028-12-31 (Class C) / 2029-12-31 (Class B).

The confirmation letter records the IVDR application and the signed written agreement. It is not an IVDR certificate, a CE certificate or an EU Declaration of Conformity, and it does not exempt any device from the remaining conformity assessment steps.

Series in this method group

SeriesDevicesDetails
Maternal & Women's Health5View list
Hepatitis2View list
Transfusion-transmitted infections1View list
Sexually transmitted infections6View list
Tropical diseases7View list
Gastrointestinal diseases10View list
Respiratory diseases8View list
Tumour markers3View list
Inflammation markers7View list
Cardiac markers5View list
Coagulation6View list
Drug of abuse screening9View list
Other tests6View list
Total75rapid lateral flow immunoassay devices

How to read these pages

Request a quote →